AGNC Investment Corp. Files 8-K on Preferred Stock Series

TL;DR

AGNC filed an 8-K detailing its preferred stock series C, D, E, F, and G.

AI Summary

AGNC Investment Corp. filed an 8-K on October 28, 2024, reporting on other events as of October 25, 2024. The filing details various series of preferred stock, including Series C, D, E, F, and G, with fixed-to-floating rates and cumulative redeemable features. Specific details on dollar amounts or significant events beyond the reporting of these preferred stock series are not provided in this excerpt.

Why It Matters

This filing provides information on AGNC's outstanding preferred stock, which is relevant for investors holding or considering these specific securities.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of preferred stock series and does not indicate any immediate financial distress or significant operational changes.

Key Players & Entities

• AGNC Investment Corp. (company) — Filer
• 7.000% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (company) — Preferred Stock Series
• 6.875% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (company) — Preferred Stock Series
• 6.500% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (company) — Preferred Stock Series
• 6.125% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (company) — Preferred Stock Series
• 7.75% Series G Fixed Rate Reset Cumulative Redeemable Preferred Stock (company) — Preferred Stock Series

FAQ

Key Financial Figures

• $0.01 — ich Registered Common Stock, par value $0.01 per share AGNC The Nasdaq Global Select
• $1.25 billion — gregate offering price of approximately $1.25 billion under Amendment No. 1 to the Original S
• $1.5 billion — ng an aggregate offering price of up to $1.5 billion (the "Shares"). Shares sold under the

Filing Documents

• agnc-20241025.htm (8-K) — 42KB
• formofamendmentno2toatmsal.htm (EX-1.1) — 25KB
• exhibit5opinion.htm (EX-5.1) — 44KB
• agnc-20241025_g1.jpg (GRAPHIC) — 715KB
• 0001423689-24-000073.txt ( ) — 1999KB
• agnc-20241025.xsd (EX-101.SCH) — 5KB
• agnc-20241025_def.xml (EX-101.DEF) — 20KB
• agnc-20241025_lab.xml (EX-101.LAB) — 40KB
• agnc-20241025_pre.xml (EX-101.PRE) — 20KB
• agnc-20241025_htm.xml (XML) — 8KB

01. Other Events

Item 8.01. Other Events As previously reported, on October 12, 2023, AGNC Investment Corp., a Delaware corporation (the "Company") entered into separate sales agreements (the "Original Sales Agreements") with each of Goldman Sachs & Co. LLC, Barclays Capital Inc., BTIG, LLC, Citigroup Global Markets Inc., Citizens JMP Securities, LLC, J.P. Morgan Securities LLC, Keefe, Bruyette & Woods, Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, Virtu Americas LLC, and Wells Fargo Securities, LLC (each, an "Agent" and collectively, the "Agents"), to implement a new "at the market" common stock issuance program under which the Company may, from time to time to or through any of the Agents, acting as agent and/or principal, offer and sell shares of its common stock, par value $0.01 per share (the "Common Stock"). On May 9, 2024, the Company entered into separate amendments to the Original Sales Agreements with each of the Agents to increase the aggregate offering price of Common Stock available for issuance under the Original Sales Agreements ("Amendment No. 1 to the Original Sales Agreements" and together with the Original Sales Agreements, the "Amended Sales Agreements."). As of October 25, 2024, in addition to the previously disclosed shares of Common Stock sold under the Original Sales Agreements, the Company has sold shares of Common Stock having an aggregate offering price of approximately $1.25 billion under Amendment No. 1 to the Original Sales Agreements. On October 25, 2024, the Company entered into separate amendments to the Amended Sales Agreements with each of the Agents to increase the aggregate offering price of Common Stock available for issuance under the Amended Sales Agreements and to revise certain other provisions of the Amended Sales Agreements ("Amendment No. 2 to the Original Sales Agreements" and, together with the Amended Sales Agreements, each, a "Sales Agreement" and collectively, the "Sales Agreements"). As a result of

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. On October 25, 2024, Skadden, Arps, Slate, Meagher & Flom LLP delivered an opinion (the "Opinion") to the Company in connection with the Company's sale of the Shares from time to time to or through the Agents. The Opinion is being filed herewith, and thereby automatically incorporated by reference into the Registration Statement, in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act of 1933. (d) Exhibits. Exhibit No. Description 1.1 Form of Amendment No. 2 to the Original Sales Agreements 5.1 Opinion of Skadden, Arps, Slate, Meagher & Flom LLP 23.1 Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.1 hereto) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AGNC INVESTMENT CORP. Dated: October 28, 2024 By: /s/ Kenneth L. Pollack Kenneth L. Pollack Executive Vice President, Chief Compliance Officer, General Counsel and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR